Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)NCT06873516EVMNPhase 2Completed2026-05-29Actual
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant DiseaseNCT06875128DCTHPhase 2Recruiting2029-05Estimated
A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating DisorderNCT06878976AXSMPhase 3Enrolling by invitation2027-12Estimated
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute PancreatitisNCT06880770Arrowhead PharmaceuticalsPhase 3Recruiting2029-03Estimated
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)NCT06881784RVMDPhase 3Recruiting2027-12-01Estimated
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease PsychosisNCT06887192MapLight TherapeuticsPhase 2Recruiting2027-12Estimated
Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple SclerosisNCT06890923TLSAPhase 2Recruiting2026-04-30Estimated
Assessing Gingivitis of 3 Different Dentifrices Compared to a Negative Control.NCT06892834Procter and GamblePhase 2Completed2025-06-19Actual
To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center HemodialysisNCT06901505Akebia TherapeuticsPhase 3Completed2026-08-12Actual
A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV InfectionNCT06903338VIRPhase 3Active not recruiting2026-09-30Actual
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological CancersNCT06906341Corcept TherapeuticsPhase 2Recruiting2027-12Estimated
A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta InfectionNCT06907290MIRMPhase 2, Phase 3Active not recruiting2029-05Estimated
A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLCNCT06908304Maia BiotechnologyPhase 3Recruiting2027-07-31Estimated
An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic SeizuresNCT06908356Praxis Precision MedicinesPhase 2Recruiting2025-07Estimated
Study of Bitopertin in Participants With EPP or XLP (APOLLO)NCT06910358IRONPhase 3Completed2026-09-08Actual
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral SupportNCT06910943Protara TherapeuticsPhase 2, Phase 3Recruiting2028-03Estimated
REVEAL: A Phase 3 Study of Obudanersen (ION582) in Angelman SyndromeNCT06914609IONSPhase 3Active not recruiting2027-08Estimated
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal CancerNCT06915025ImunonPhase 3Recruiting2032-10-31Estimated
A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the AnkleNCT06915233Vericel CorporationPhase 3Recruiting2030-07Estimated
An Open-Label Study of Azetukalner in Major Depressive DisorderNCT06922110XENEPhase 3Active not recruiting2027-01Estimated
A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)NCT06924970AGIOPhase 2Active not recruiting2026-05-12Actual
An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous UrticariaNCT06927999SPRYPhase 2Recruiting2027-06Estimated
A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)NCT06941844Definium Therapeutics US, Inc.Phase 3Active not recruiting2026-05-20Actual
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine TumorsNCT06943755ExelixisPhase 2, Phase 3Recruiting2029-06-30Estimated
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)NCT06951217AVLNPhase 2Recruiting2031-12-31Estimated
Clinical Study of QRX003 Lotion in Subjects With Netherton SyndromeNCT06953466Quoin PharmaceuticalsPhase 2, Phase 3Recruiting2026-12-30Estimated
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric InsomniaNCT06953869Vanda PharmaceuticalsPhase 3Recruiting2027-11Estimated
STOP-HAE: A Phase 3 Study of ADX-324 in HAENCT06960213ADRXPhase 3Recruiting2027-11-30Estimated
Randomized Withdrawal Study in Patients With SchizophreniaNCT06961968Vanda PharmaceuticalsPhase 3Recruiting2027-11Estimated
A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)NCT06963710Aligos TherapeuticsPhase 2Active not recruiting2027-03Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.